Annual Net Income
-$30.01 M
-$2.71 M-9.92%
31 December 2023
Summary:
INmune Bio annual net profit is currently -$30.01 million, with the most recent change of -$2.71 million (-9.92%) on 31 December 2023. During the last 3 years, it has fallen by -$17.91 million (-148.02%). INMB annual net income is now -10713.69% below its all-time high of -$277.50 thousand, reached on 31 December 2016.INMB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$12.09 M
-$2.35 M-24.08%
30 September 2024
Summary:
INmune Bio quarterly net profit is currently -$12.09 million, with the most recent change of -$2.35 million (-24.08%) on 30 September 2024. Over the past year, it has dropped by -$3.53 million (-41.22%). INMB quarterly net income is now -3832.68% below its all-time high of -$307.50 thousand, reached on 30 September 2017.INMB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$41.27 M
-$3.53 M-9.35%
30 September 2024
Summary:
INmune Bio TTM net profit is currently -$41.27 million, with the most recent change of -$3.53 million (-9.35%) on 30 September 2024. Over the past year, it has dropped by -$13.84 million (-50.45%). INMB TTM net income is now -13321.79% below its all-time high of -$307.50 thousand, reached on 30 September 2017.INMB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.9% | -41.2% | -50.5% |
| 3 y3 years | -148.0% | -27.9% | -72.9% |
| 5 y5 years | -141.2% | -294.3% | -470.1% |
INMB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -148.0% | +1.1% | -107.3% | at low | -72.9% | at low |
| 5 y | 5 years | -290.8% | +1.1% | -484.2% | at low | -470.1% | at low |
| alltime | all time | <-9999.0% | +1.1% | -3832.7% | at low | <-9999.0% | at low |
INmune Bio Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.09 M(+24.1%) | -$41.27 M(+9.4%) |
| June 2024 | - | -$9.75 M(-11.6%) | -$37.74 M(+9.4%) |
| Mar 2024 | - | -$11.03 M(+31.1%) | -$34.50 M(+15.0%) |
| Dec 2023 | -$30.01 M(+9.9%) | -$8.41 M(-1.8%) | -$30.01 M(+9.4%) |
| Sept 2023 | - | -$8.56 M(+31.7%) | -$27.43 M(+3.2%) |
| June 2023 | - | -$6.50 M(-0.5%) | -$26.59 M(-1.3%) |
| Mar 2023 | - | -$6.54 M(+12.1%) | -$26.93 M(-1.3%) |
| Dec 2022 | -$27.30 M(-10.0%) | -$5.83 M(-24.5%) | -$27.30 M(-12.3%) |
| Sept 2022 | - | -$7.72 M(+13.0%) | -$31.14 M(-5.3%) |
| June 2022 | - | -$6.84 M(-0.9%) | -$32.87 M(+0.6%) |
| Mar 2022 | - | -$6.90 M(-28.6%) | -$32.69 M(+7.7%) |
| Dec 2021 | -$30.34 M(+150.8%) | -$9.67 M(+2.3%) | -$30.34 M(+27.1%) |
| Sept 2021 | - | -$9.46 M(+42.1%) | -$23.87 M(+24.8%) |
| June 2021 | - | -$6.66 M(+46.1%) | -$19.13 M(+31.2%) |
| Mar 2021 | - | -$4.56 M(+42.2%) | -$14.59 M(+20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$12.10 M(+57.6%) | -$3.20 M(-32.1%) | -$12.10 M(+7.9%) |
| Sept 2020 | - | -$4.72 M(+123.8%) | -$11.21 M(+17.3%) |
| June 2020 | - | -$2.11 M(+1.8%) | -$9.56 M(+21.9%) |
| Mar 2020 | - | -$2.07 M(-10.7%) | -$7.85 M(+2.2%) |
| Dec 2019 | -$7.68 M(-38.3%) | -$2.32 M(-24.4%) | -$7.68 M(+6.1%) |
| Sept 2019 | - | -$3.07 M(+682.2%) | -$7.24 M(+26.7%) |
| June 2019 | - | -$392.10 K(-79.4%) | -$5.71 M(-50.3%) |
| Mar 2019 | - | -$1.90 M(+1.1%) | -$11.49 M(-7.6%) |
| Dec 2018 | -$12.44 M(+1396.1%) | -$1.88 M(+22.1%) | -$12.44 M(+13.2%) |
| Sept 2018 | - | -$1.54 M(-75.1%) | -$10.99 M(+12.6%) |
| June 2018 | - | -$6.17 M(+116.9%) | -$9.76 M(+172.4%) |
| Mar 2018 | - | -$2.85 M(+564.7%) | -$3.58 M(+386.9%) |
| Dec 2017 | -$831.50 K(+199.6%) | -$428.20 K(+39.3%) | -$735.70 K(+139.3%) |
| Sept 2017 | - | -$307.50 K | -$307.50 K |
| Dec 2016 | -$277.50 K | - | - |
FAQ
- What is INmune Bio annual net profit?
- What is the all time high annual net income for INmune Bio?
- What is INmune Bio annual net income year-on-year change?
- What is INmune Bio quarterly net profit?
- What is the all time high quarterly net income for INmune Bio?
- What is INmune Bio quarterly net income year-on-year change?
- What is INmune Bio TTM net profit?
- What is the all time high TTM net income for INmune Bio?
- What is INmune Bio TTM net income year-on-year change?
What is INmune Bio annual net profit?
The current annual net income of INMB is -$30.01 M
What is the all time high annual net income for INmune Bio?
INmune Bio all-time high annual net profit is -$277.50 K
What is INmune Bio annual net income year-on-year change?
Over the past year, INMB annual net profit has changed by -$2.71 M (-9.92%)
What is INmune Bio quarterly net profit?
The current quarterly net income of INMB is -$12.09 M
What is the all time high quarterly net income for INmune Bio?
INmune Bio all-time high quarterly net profit is -$307.50 K
What is INmune Bio quarterly net income year-on-year change?
Over the past year, INMB quarterly net profit has changed by -$3.53 M (-41.22%)
What is INmune Bio TTM net profit?
The current TTM net income of INMB is -$41.27 M
What is the all time high TTM net income for INmune Bio?
INmune Bio all-time high TTM net profit is -$307.50 K
What is INmune Bio TTM net income year-on-year change?
Over the past year, INMB TTM net profit has changed by -$13.84 M (-50.45%)